The DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship
Open accessAbstract
Melanin pigment plays a critical role in the protection against the harmful effects of ultraviolet radiation and other environmental stressors. It is produced by the enzymatic transformation of L-tyrosine to dopaquinone and subsequent chemical and biochemical reactions resulting in the formation of various 5,6-dihydroxyindole-2-carboxylic acid (DHICA) and 5,6-dihydroxyindole (DHI) oligomers—main constituents of eumelanin, and benzothiazine and benzothiazole units of pheomelanin. The biosynthesis of melanin is regulated by sun exposure and by many hormonal factors at the tissue, cellular, and subcellular levels. While the presence of melanin protects against the development of skin cancers including cutaneous melanoma, its presence may be necessary for the malignant transformation of melanocytes. This shows a complex role of melanogenesis in melanoma development defined by chemical properties of melanin and the nature of generating pathways such as eu- and pheomelanogenesis. While eumelanin is believed to provide radioprotection and photoprotection by acting as an efficient antioxidant and sunscreen, pheomelanin, being less photostable, can generate mutagenic environment after exposure to the short-wavelength UVR. Melanogenesis by itself and its highly reactive intermediates show cytotoxic, genotoxic, and mutagenic activities, and it can stimulate glycolysis and hypoxia-inducible factor 1-alpha (HIF-1α) activation, which, combined with their immunosuppressive effects, can lead to melanoma progression and resistance to immunotherapy. On the other hand, melanogenesis-related proteins can be a target for immunotherapy. Interestingly, clinicopathological analyses on advanced melanomas have shown a negative correlation between tumor pigmentation and diseases outcome as defined by overall survival and disease-free time. This indicates a “Yin and Yang” role for melanin and active melanogenesis in melanoma development, progression, and therapy. Furthermore, based on the clinical, experimental data and diverse effects of melanogenesis, we propose that inhibition of melanogenesis in advanced melanotic melanoma represents a realistic adjuvant strategy to enhance immuno-, radio-, and chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–213 of 213
Hyter, S. D., Bajaj, G., Liang, X., Barbacid, M., Ganguli‐Indra, G., & Indra, A. K. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00732.x · Cited by 21
Melanocyte biology and melanogenesis: what's new?
Ortonne, J. ‐., & Ballotti, R. (2000) · Journal of Dermatological Treatment · doi:10.1080/09546630050517621 · Cited by 21
L-Dopa binding sites in rodent melanoma cells
Slominski, A. T., & Pruski, D. (1992) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(92)90109-z · Cited by 19
Self-citationNeoantigen-Reactive T Cells: The Driving Force behind Successful Melanoma Immunotherapy
Davis, L., Tarduno, A., & Lu, Y. (2021) · Cancers · doi:10.3390/cancers13236061 · Cited by 19
Sister chromatid exchange (SCE) rates in human melanoma cells as an index of mutagenesis
Miranda, M., Ligas, C., Amicarelli, F., D’Alessandro, E., Brisdelli, F., Zarivi, O., & Poma, A. M. (1997) · Mutagenesis · doi:10.1093/mutage/12.4.233 · Cited by 18
L‐DOPA Inhibits In Vitro Phosphorylation of Melanoma Glycoproteins
Slominski, A. T., & FRIEDRICH, T. (1992) · Pigment Cell Research · doi:10.1111/j.1600-0749.1992.tb00569.x · Cited by 17
Self-citationLembo, S., Caprio, R. D., Micillo, R., Balato, A., Monfrecola, G., Panzella, L., & Napolitano, A. (2016) · Experimental Dermatology · doi:10.1111/exd.13122 · Cited by 17
The influence of iron on selected properties of synthetic pheomelanin
Żądło, A. C., Mokrzynski, K. T., Ito, S., Wakamatsu, K., & Sarna, T. (2020) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-020-00918-1 · Cited by 13
Self-citationPawelek, J. M., Bolognia, J. L., McLane, J. A., Murray, M., Osber, M. P., & Slominski, A. T. (1988) · PubMed · Cited by 12
Self-citationZielińska, K., Kozłowska, K., Cichorek, M., & Wachulska, M. (2008) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-008-0041-4 · Cited by 6
Black is beautiful (and protective): melanin synthesis in animals and plants
Nick, P. A. (2021) · PROTOPLASMA · doi:10.1007/s00709-021-01693-3 · Cited by 5
Ultrastructure of transplantable melanotic and amelanotic melanoma of hamsters.
Bomirski, A., Zawrocka-Wrzołkowa, T., & Pautsch, F. (1971) · PubMed · Cited by 3
Mitochondrial sirtuins at the crossroads of energy metabolism and oncogenic transformation
Grabacka, M., & Plonka, P. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822467-0.00001-2 · Cited by 3
Cited by
Environmental Air Pollutants Affecting Skin Functions with Systemic Implications
Bocheva, G., Slominski, R. M., & Slominski, A. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310502 · Cited by 94
Self-citationSignificance of melanin distribution in the epidermis for the protective effect against UV light
Zamudio Díaz, D. F., Busch, L., Kröger, M., Klein, A. L., Lohan, S. B., Mewes, K. R., Vierkotten, L., Witzel, C., Rohn, S., & Meinke, M. C. (2024) · Scientific Reports · doi:10.1038/s41598-024-53941-0 · Cited by 71
Metadata
- Authors
- Slominski, R. M., Sarna, T., Płonka, P. M., Raman, C., Brożyna, A. A., & Slominski, A. T.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2022-03-14
- Volume
- 12
- Pages
- 842496-842496
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W4220766102
- Cited by
- 286
- References
- 213
- FWCI
- 26.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.